Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:NIO
NYSE:NIOAuto

Is NIO (NIO) Fairly Priced After Recent Share Price Recovery?

If you are wondering whether NIO at about US$4.89 is a bargain or a value trap, you are not alone. This breakdown is here to unpack that question in more detail. The share price has moved 8.2% over the last week and 5.4% over the last 30 days, while the year to date return is a 4.9% decline and the 1 year return sits at 12.9%. This compares with much weaker 3 year and 5 year returns of 52.6% and 91.8% declines respectively. Recent coverage of NIO has focused on its position in the electric...
NYSE:KLAR
NYSE:KLARDiversified Financial

Assessing Klarna Group (KLAR) Valuation After Recent Share Price Weakness And Conflicting Fair Value Signals

Why Klarna Group is on investors’ radar Klarna Group (KLAR) has drawn attention after recent trading, with the share price at US$20.37 and short term returns under pressure over the past week, month, and past 3 months. See our latest analysis for Klarna Group. For context, Klarna Group’s recent weakness has been building for a while, with a 1-day share price return of 0.73% decline, a 30-day share price return of 35.23% decline, and a year to date share price return of 28.70% decline. This...
TSE:4568
TSE:4568Pharmaceuticals

A Look At Daiichi Sankyo (TSE:4568) Valuation After DATROWAY Priority Review Milestone

Daiichi Sankyo Company (TSE:4568) shares are in focus after the U.S. FDA accepted and granted Priority Review to a supplemental Biologics License Application for DATROWAY in advanced triple negative breast cancer. See our latest analysis for Daiichi Sankyo Company. At a share price of ¥2,952.0, Daiichi Sankyo’s 1 day share price return of 2.89% and 7 day gain of 1.22% contrast with a 30 day share price decline of 16.66% and a 1 year total shareholder return of 19.19% in the red. This suggests...
TSE:7733
TSE:7733Medical Equipment

Olympus (TSE:7733) Valuation Check As New HR And Manufacturing Leaders Join The MedTech Push

Olympus (TSE:7733) has reshaped its senior leadership by appointing Simone Berger as Chief Human Resources Officer and David Shan as Chief Manufacturing and Supply Officer, effective April 1, 2026, following a board meeting that reviewed executive roles. See our latest analysis for Olympus. The executive reshuffle comes after a softer patch for the stock, with a 30 day share price return decline of 7.05% and a 1 year total shareholder return decline of 11.96%, while the recent 7 day share...
NYSE:JMIA
NYSE:JMIAMultiline Retail

Has Jumia Technologies (JMIA) Run Too Far After Its 196% One-Year Share Price Surge?

If you are wondering whether Jumia Technologies is still attractively priced after its recent volatility, you are not alone. This article will walk through what the current market price might be implying. The stock last closed at US$12.27, with returns of 195.7% over 1 year and 225.5% over 3 years, alongside shorter term moves of a 0.7% decline over 7 days, a 14.0% decline over 30 days, and a 4.4% decline year to date. These mixed returns, strong over several years but weaker in the near...